Evidence map›Paper›PMID 41913449›Full record

ArticleAnnals of transplantation2026

Retrospective Analysis of Risk Factors and Surgical Outcomes in Liver Transplant Recipients.

Jamilya Saparbay, Abylaikhan Sharmenov, Chokhan Aytbayev, Assylmurat Zhumukov, Bekkhozha Yeskendirov, Zhanat Spatayev, Zhandos Burkitbayev

Abstract read
In one paragraph

Article in Annals of transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jamilya SaparbayNazarbayev University Medicine/School of Medicine, Astana, Kazakhstan.ORCID 0000-0002-8478-5452
Abylaikhan SharmenovGastroenterology and Transplant Surgery Department, National Research Oncology Center, Astana, Kazakhstan.ORCID 0000-0002-7091-1331
Chokhan AytbayevGastroenterology and Transplant Surgery Department, National Research Oncology Center, Astana, Kazakhstan.ORCID 0009-0007-8356-5881
Assylmurat ZhumukovGastroenterology and Transplant Surgery Department, National Research Oncology Center, Astana, Kazakhstan.ORCID 0009-0003-3234-5396
Bekkhozha YeskendirovGastroenterology and Transplant Surgery Department, National Research Oncology Center, Astana, Kazakhstan.
Zhanat SpatayevGastroenterology and Transplant Surgery Department, National Research Oncology Center, Astana, Kazakhstan.ORCID 0000-0003-1659-431X
Zhandos BurkitbayevGastroenterology and Transplant Surgery Department, National Research Oncology Center, Astana, Kazakhstan.ORCID 0009-0000-4859-1637

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Liver transplantation (LT) is the definitive treatment for selected patients with end-stage liver disease (ESLD), yet postoperative complications remain a major challenge, particularly in regions where living donor liver transplantation (LDLT) predominates. This study aimed to evaluate surgical outcomes, identify predictors of early mortality, and assess the incidence and impact of biliary complications in a low-volume transplant center in Central Asia. MATERIAL AND METHODS We retrospectively analyzed 113 liver transplantations performed at the National Research Oncology Center between 2013 and 2025. The cohort comprised 88 LDLT (77.9%) and 25 deceased donor LT (DDLT) cases, with a mean recipient age of 43.8 years. RESULTS The overall 1-, 3-, 5-, 7-, and 10-year survival rates were 76.3%, 72.9%, 70.0%, 70.0%, and 70.0%, respectively, with no significant difference between LDLT and DDLT. Biliary leakage (BL) and biliary stricture (BS) occurred in 26.5% and 20% of recipients, respectively. Graft steatosis and external bile duct (EBD) stenting were independent predictors of BL, while intraoperative bleeding and EBD predicted BS. Hepatic artery thrombosis (HAT) occurred in 14.1% of patients and was a significant predictor of 90-day mortality. Sepsis was the strongest predictor of 30-day (OR 7.92, P=0.022) and 90-day mortality (OR 20.1, P CONCLUSIONS Biliary complications remain common, particularly in LDLT, and are influenced by graft and reconstruction factors. Advances in surgical technique, infection control, and early recognition of vascular complication remain decisive for optimizing outcomes after liver transplantation.

Indexed as

End Stage Liver DiseaseLiver TransplantationPostoperative ComplicationsAdultFemaleHumansLiving DonorsMaleMiddle AgedRetrospective StudiesRisk FactorsSurvival RateTreatment Outcome

Identifiers

PMID41913449
PMCPMC13050130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.